Biological Variation The logical source for analytical goals
|
|
- Audrey Harmon
- 6 years ago
- Views:
Transcription
1 Biological Variation The logical source for analytical goals Presented by: John Yundt-Pacheco Scientific Fellow Quality Systems Division Bio-Rad Laboratories
2 Acknowledgements Dr. Callum Fraser Clinical Leader of Biochemical Medicine Ninewells Hospital and Medical School Dundee Scotland Biological Variation: From Principles To Practice, AACC Press 2001 General strategies to set quality specifications for reliability performance characteristics. Scand J Clin Lab Invest.,1999 Vol Dr. Carmen Ricos Vall d Hebron General Hospital Vall d Hebron, Barcelona, Spain Ricos C et. al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest.,1999 Vol
3 Objectives Understand the hierarchy of strategies to set quality specifications Understand where biological variation based analytical goals come from Understand the difference between the minimum, desirable, and optimum biological variation analytical goals
4 The Need for Quality Specifications Quality specifications dictate the performance characteristics that must be realized in our test systems for them to satisfy their purpose. In the absence of quality specifications, there is no way to determine whether the control procedures being utilized are appropriate.
5 Which Quality Specifications? How does the non-expert know what quality specifications should be used? To answer this question, a conference was organized in Stockholm, Sweden in April 1999 by the IFCC, WHO and the International Union of Pure and Applied Chemistry (IUPAC). Participants with published papers on various quality specification models attended from 23 countries.
6 The Stockholm Conference Consensus Statement The Stockholm Conference ended with a consensus statement agreeing on a hierarchical model of quality specification desirability. This consensus statement and articles by the most influential conference participants was published in a special issue of The Scandinavian Journal of Clinical & Laboratory Investigation volume 59, no 7, November 1999.
7 The Quality Specification Hierarchy 1. Quality specifications in specific clinical situations 2. Quality specifications based on general clinical use of test results 3. Quality specifications from professional recommendations 4. Quality specifications based on regulation and external quality assessment.
8 The Quality Specification Hierarchy Continued 5. Quality specifications based on State of the Art. Not covered in the hierarchy is the wildly popular, inertia-based, implicit quality specification - as in We use the 1:2 s rule, er, because we always have
9 1 - Specific Clinical Situations The ideal error specification is based on assessing how analytical performance affects specific clinical decisions. The problem is that very little of this analysis has been done in a manner that lends itself to universal use. If results from are treated the same, but a 111 is treated differently, a 10% error tolerance is implied.
10 2 - General Clinical Situations Quality specifications based on the general clinical use of the results fall into to groups: Specifications based on Biological Variation Specifications based on the analysis of clinician s opinions
11 2b- Analysis of Clinicians Opinions Quality specifications can be derived by interviewing a number of clinicians about how they would interpret clinical results. A 63-year old man with high bloodpressure has a cholesterol value of 6.60 mmol/l. You advise him to change his lifestyle and diet. You review him after 2 months. What level of cholesterol would indicate to you that he took your advice?
12 Converting Opinions to Specifications Because this particular interview is about change over time of the results of a single individual, it can be used for determining a precision specification. The median of the differences between the responses and 6.60 can be converted into an analytical specification for precision.
13 3 - Professional Recommendations Various groups of experts have published quality specifications for specific sets of analytes. The National Cholesterol Education Panel in the US has published recommendations for the precision, accuracy and total allowable error for lipids. The American Diabetes Association has documented quality specifications for selfmonitoring blood glucose, etc.
14 4 - Regulatory Agencies Mandated performance goals set by regulation like CLIA 88 CLIA 88 specifies the Total Allowable Error for glucose as 10% at values 60 mg/dl or higher. Outside the US, proficiency programs have a variety of mechanisms for grading performance. They can all be translated into a analytical goal specification.
15 5 State of the Art State of the Art refers to deriving quality specifications by what is possible currently. An example of a State of the Art precision specification might be the median CV from a group of laboratories. State of the Art specifications can be derived from proficiency testing programs or inter-laboratory consensus programs.
16 inertia-based implicit specifications Quality specifications can be implicitly defined given the set of control rules in use. This is the most common form of quality specification used in the world, but it is clearly not optimal. Any of the previously discussed quality models is superior to an implicit quality specification.
17 Biological Variation Biological variation-based quality specifications are derived by evaluating the inherent biological variation of an analyte and determining how large imprecision and bias can be before they mask significant changes in the analyte.
18 Biological Variation Specifications Quality specifications based on biological variation have the following benefits: Firmly based on medical requirements Usable in all laboratories Generated using simple models Widely accepted
19 Components of Biological Variation Biological variation can be broken into two components: Within subject variation (CV w also referred to as CV I ) the normal amount of variation that is present in a human. Between subject variation (CV b also referred to as CV G ) the normal difference that is found between humans.
20 Illustration of Within Subject and Between Subject Biological Variation. Means and ranges of IgG concentrations in 12 healthy individuals. CV w = 4.5 CV b = 16.5 TE a = 9.5 Fraser CG, Harris E. Generation and Application of Data on Biological Variation in Clinical Chemistry. Crit Rev Clin Lab Sci 1989;27:420
21 Obtaining Biological Variation Data A database of biological variation data has been compiled by Dr. Carmen Ricos and her colleagues. They reviewed some 190 publications and compiled consensus values for CVw and CV B for 265 analytes. This database is published at and as well as other places.
22
23 Where Glucose BV Values Came From Costongs GMPJ, Janson PCW, Bas BM. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem 1985; 23: Davie SJ, Whiting KL, Gould BJ. Biological variation in glycated proteins. Ann Clin Biochem 1993; 30: Eckfeldt J,Chambless Ll, Shen Y. Short-term, Within-Person Variability in Clinician Chemistry test results.arch Pathol Lab Med 1994; 118: Fraser CG, Williams P. Short-term biological variation of plasma analytes in renal disease. Clin Chem1983;29: Fraser Callum G., Cummings Steven T., Wilkinson Stephen P., Neville Ronald G., Knox James D. E., Ho Olga, and MacWalter Ronald S.. Biological variability of 26 clinical chemistry analytes in elderly people.. Clin Chem 1989; 35: Godslang IF. Intra-individual variation: significant changes in parameters of lipid and carbohydrate metabolism in the individual andintra-individual variation in different test populations. Ann Clin Biochem 1985;22: 618:624
24 Where Glucose BV Values Came From Harris EK, Kanofsky P, Shakarji G and Cotlove E. Biological and analytic components of variation in longterm studies of serum constituents in normal subjects. Clin Chem 1970; 16: Juan-Pereira L. Variabilitat biologica intraindividual de les magnitudes bioquimiques. Aplicacions cliniques..doctoral Thesis, Barcelona University Ricós C, Codina R. La variabilidad biológica intraindividual como objeto de calidad analítica.. Rev Diag Biol 1989; 38: Ricos C, García-Arumí E, Rodriguiez-Rubio R, Schwartz S. Eficacia de un programa interno de controlde calidad. Quim Clin 1986; 5: Williams GZ, Widdowson GM and Penton J. Individual Character of Variation in Time-Series Studies of Healthy People II. Differences in Values for Clinical Chemical Analytes in Serum among Demographic Groups by Age and Sex. Clin Chem 1978; 24: Young DS, Harris EK and Cotlove E. Biological and Analytic Components of Variation in Long-Term Studies of Serum Constituents in Normal Subjects. Clin Chem 1971; 17: Rohlfing C, Wiedmeyer HM, Little R, Grota L, Tennill A, England J, Madsen R, Goldstein D. Biological variaiton of glycohemoglobin. Clin Chem 2002;48:
25 CV w and CV b as Quality Specifications Imprecision and Bias specifications can be derived from CV w and CV b with the following equations: Where 0.5 and are factors depending on the quality specification desired.
26 Ratio of CV A /CV I and Variation CV A /CV I Amount of Variation Added
27 Total Allowable Error Specification Total Allowable Error is the combination of the allowable imprecision multiplied by a z factor and the allowable bias:
28 Minimum, Desirable and Optimum Performance Specifications Three sets of performance specifications have been derived for biological variation values: 1. Minimum performance 25% increase 2. Desirable performance 12% increase 3. Optimum performance 3% increase Increase in CV I due to CV A
29 Minimum, Desirable and Optimum Factors Minimum uses 0.75 CV w Desirable uses 0.50 CV w Optimum uses 0.25 CV w
30 Z-scores and Probability Probability 99% 98% 97% 96% 95% 90% 85% 80% Unidirectional Bidirectional
31 Reference Change Value (1/3) RCV is the change in value over time that denotes a significant rise or fall in the concentration of the analyte measured RCV = Z * [(CV A ) 2 + (CV I ) 2 ] 1/2 With 2 results the variation is (variation of the first result 2 + variation of the second result 2 ) 1/2 For 2 results RCV = 2 1/2 + Z * [(CV A ) 2 + (CV I ) 2 ] 1/2
32 Reference Change Value (2/3) First value = 6.60 mmol/l Second value = 5.82 mmol/l Change = = 0.78 mmol/l Equivalent to (0.78/6.60) / 100 = 11.8% RCV = 2 1/2 + Z * [(CV A ) 2 + (CV I ) 2 ] 1/2 2 1/2 = Z = 1.96 for significant change or 2.58 for highly significant CV A = 1.6% CV I = 6%
33 Reference Change Value (3/3) Significant change RCV = * 1.96 * ( ) 1/2 = 17.2% Highly significant change RCV = * 2.58 * ( ) 1/2 = 22.6% Change of 11.8% is not significant.
34 Which specifications should be used? The Biological Variation databases are published using the Desirable specification. If these values are not obtainable, the Minimum specification should be used. There is little value in achieving better than Optimum performance.
35 Conclusions Consideration should be given to what quality specifications are used. Biological variation-based quality specifications are a very defensible and logical selection. Minimum, Desirable, and Optimum factors can be used to tune the biological variation specifications for values achievable and suitable for your laboratory.
36 Thank you!
Performance criteria based on biological variation. Reliability of available biological variation information: need for improvement
Performance criteria based on biological variation Reliability of available biological variation information: need for improvement Anna Carobene H San Raffaele, Milan Member of EFLM Biological Variation
More informationAnalytical Goal-Setting for Monitoring Patients When Two Analytical Methods Are Used
CLIN. CHEM. 38/11, 58-6 (199) Analytical Goal-Setting for Monitoring Patients When Two Analytical Methods Are Used Per Hyltoft Petersen, Callum G. Fraser, James. Westgard,3 and Mogens Lytken Larsen Serial
More information(a) y = 1.0x + 0.0; r = ; N = 60 (b) y = 1.0x + 0.0; r = ; N = Lot 1, Li-heparin whole blood, HbA1c (%)
cobas b system - performance evaluation Study report from a multicenter evaluation of the new cobas b system for the measurement of HbAc and lipid panel Introduction The new cobas b system provides a point-of-care
More informationSetting of quality standards
Setting of quality standards Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney AACB ASM Adelaide October 2014 Setting of Quality Standards - 2013 The 2013 QC workshop revealed
More informationDubrovnik 2014 Sverre Sandberg, Norwegian Quality Improvement of Primary Care Laboratories Noklus, Bergen, Norway
POC testing instruments for diagnosing and monitoring diabetes in clinical settings Dubrovnik 2014 Sverre Sandberg, Norwegian Quality Improvement of Primary Care Laboratories Noklus, Bergen, Norway Does
More informationPatricia C. Fallest-Strobl, 1 Elin Olafsdottir, 2 Donald A. Wiebe, 1 and James O. Westgard 1 * Lipoproteins
Clinical Chemistry 43:11 2164 2168 (1997) Lipids and Lipoproteins Comparison of NCEP performance specifications for triglycerides, HDL-, and LDL-cholesterol with operating specifications based on NCEP
More informationMETHOD VALIDATION: WHY, HOW AND WHEN?
METHOD VALIDATION: WHY, HOW AND WHEN? Linear-Data Plotter a,b s y/x,r Regression Statistics mean SD,CV Distribution Statistics Comparison Plot Histogram Plot SD Calculator Bias SD Diff t Paired t-test
More informationShould HbA1C measured by POC instruments be used for diagnosis of diabetes? Sverre Sandberg, Norwegian Quality Improvement of Primary Care
Should HbA1C measured by POC instruments be used for diagnosis of diabetes? Sverre Sandberg, Norwegian Quality Improvement of Primary Care Laboratories Noklus, Bergen, Norway NOKLUS a POC organisation
More informationDr Bill Bartlett Blood Sciences, Ninewells Hospital & Medical School, NHS Tayside, Scotland, UK.
Dr Bill Bartlett Blood Sciences, Ninewells Hospital & Medical School, NHS Tayside, Scotland, UK. Bill.Bartlett@nhs.net www.biologicalvariation.com Biological variation affects the clinical utility of reference
More informationIntroduction. Noklus. Opinion Paper
Clin Chem Lab Med 2015; 53(6): 857 862 Opinion Paper Noklus Geir Thue and Sverre Sandberg* Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical
More informationREVIEW Global standardisation of HbA 1c
Malaysian J Pathol 2008; 30(2) : 67 71 REVIEW Global standardisation of Leslie C LAI, FRCP, FRCPath Gleneagles Intan Medical Centre, Kuala Lumpur, Malaysia Abstract is used for assessing glycaemic control
More informationA comparison of analytical goals for haemoglobin A1, assays derived using different strategies
Original Article Ann Clin Biochem 1991; 28: 272-278 A comparison of analytical goals for haemoglobin A1, assays derived using different strategies Mogens Lytken Larsen, Callum G Fraser and Per Hyltoft
More informationAnalytical Performance in the The Test Evaluation Cycle
Analytical Performance Specifications based on Outcome Studies: Is it possible? Test Evaluation Working Group of EFLM www.efcclm.eu SEALS Department of Clinical Chemistry, Prince of Wales Hospital, Sydney
More informationBIOLOGICAL VARIABILITY: THE CIRME CONTRIBUTION. F. Braga Centre for Metrological Traceability in Laboratory Medicine (CIRME)
BIOLOGICAL VARIABILITY: THE CIRME CONTRIBUTION F. Braga Centre for Metrological Traceability in Laboratory Medicine (CIRME) TOTAL VARIATION (CV (CV T ) T ) PREANALYTICAL VARIATION ANALYTICAL VARIATION
More informationQuality Specifications for POCT
Quality Specifications for POCT the patient journey perspective Christopher P Price Department of Clinical Biochemistry, University of Oxford, Oxford, UK Quality Specifications fit-for-purpose QUALITY
More informationIndividual Lab Report Ci-Trol Nov,2016. Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC Your Lab
Individual Lab Report Ci-Trol Nov,2016 ST VINCENT MEDICAL CENTER LABORATORY(LAB# 7300 ) 2131 WEST THIRD STREET LOS ANGELES CA USA 90057 Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC SYSMEX
More informationPostanalytical External Quality Assessment of Blood Glucose and Hemoglobin A 1c : An International Survey
Clinical Chemistry 51:7 1145 1153 (2005) Evidence-Based Laboratory Medicine and Test Utilization Postanalytical External Quality Assessment of Blood Glucose and Hemoglobin A 1c : An International Survey
More informationBiological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum
Papers in Press. Published April 20, 2017 as doi:10.1373/clinchem.2016.269811 The latest version is at http://hwmaint.clinchem.aaccjnls.org/cgi/doi/10.1373/clinchem.2016.269811 Clinical Chemistry 63:6
More informationMonitoring Diabetes Mellitus with HBA 1 C: The Abakaliki, Nigeria Experience
Monitoring Diabetes Mellitus with HBA 1 C: The Abakaliki, Nigeria Experience Kayode Julius, Adebayo (corresponding author) Chemical Pathology department,faculty of Clinical Sciences, College of Medicine,
More informationMonday and non-monday concentrations of lifestyle-related blood components in the Oslo Diet and Exercise Study
Journal of Internal Medicine 1998; 244: 507 513 JINT395 Monday and non-monday concentrations of lifestyle-related blood components in the Oslo Diet and Exercise Study P. URDAL 1, S. A. ANDERSSEN 2, I.
More informationGuide to Fulfillment of Measurement Uncertainty
DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca
More informationA validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls
A validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls Shyamali Pal R B Diagnostic Private Limited, Lake Town, Kolkata, India INFO ABSTRACT Corresponding
More informationEvaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
Received: 19 September 2018 Revised: 7 October 2018 Accepted: 18 October 2018 DOI: 10.1002/jcla.22715 RESEARCH ARTICLE Evaluation of biological variation of glycated hemoglobin and glycated albumin in
More informationBias in clinical chemistry. Elvar Theodorsson EFLM and Linköping University
Bias in clinical chemistry Elvar Theodorsson EFLM and Linköping University Bias a controversial subject Different perspectives Reseachers Users Regulatory bodies Standardisation organisations Metrologists
More informationClinica Chimica Acta
Clinica Chimica Acta 41 (011) 141 1416 Contents lists available at ScienceDirect Clinica Chimica Acta journal homepage: www.elsevier.com/locate/clinchim Revaluation of biological variation of glycated
More informationADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values - New Treatment Guidelines Will Now be Needed
529638DSTXXX10.1177/1932296814529638Journal of Diabetes Science and TechnologyKlonoff research-article2014 Editorial ADAG Study Group Data Links A1C Levels with Empirically Measured Blood Glucose Values
More informationTechnical Bulletin. Cholesterol Reference Method Laboratory Network (CRMLN) Overview. TB Rev. 0
Technical Bulletin Reference Method Laboratory Network (CRMLN) Overview TB000020 Rev. 0 Reference Method Laboratory Network (CRMLN) - General Information With guidance from the US Centers for Disease Control
More informationThe Integrated Cardiovascular Clinical Network CHSA
The Integrated Cardiovascular Clinical Network CHSA Roche cobas b 101 HbA1c and Lipids Evaluation July 2013 Introduction Cardiovascular disease (CVD) is the leading cause of mortality in Australia, accounting
More informationAnalytical performance specifications two years after Milan conference. Prof Mauro Panteghini CIRME Scientific Coordinator
Analytical performance specifications two years after Milan conference Prof Mauro Panteghini CIRME Scientific Coordinator Definition Analytical performance specifications: Criteria that specify (in numerical
More informationThe influence of sample freezing at 80 C for 2 12 weeks on glycated haemoglobin (HbA 1c
Original papers The influence of sample freezing at 80 C for 2 12 weeks on glycated haemoglobin ( ) method on Bio-Rad D-10 auto analyzer Katarzyna Bergmann*, Grazyna Sypniewska Department of Laboratory
More informationMaintaining Quality in Laboratory Medicine. Glycated Haemoglobin Scheme Guide
Maintaining Quality in Laboratory Medicine Glycated Haemoglobin Scheme Guide Contents 1. Scheme Details and repertoire 1.1 Source Material and Serum Integrity 3 1.2 List of Analytes and Frequency of Distribution
More informationassay Introduction Conclusions: The D-100 TM system proved to be a robust and reliable method for HbA 1c
Clin Chem Lab Med 215; aop Stéphane Jaisson*, Nathalie Leroy, Emmanuelle Guillard, Aurore Desmons and Philippe Gillery Analytical performances of the D- TM hemoglobin testing system (Bio-Rad) for assay
More informationRelationship between glucose meter error and glycemic control efficacy
Relationship between glucose meter error and glycemic control efficacy Brad S. Karon, M.D., Ph.D. Professor of Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology Mayo Clinic
More informationState of the Art of HbA1c Measurement
State of the Art of HbA1c Measurement XXI Congreso Latinoamericano de Patologia Clinica Y XLII Congreso Mexicano de Patologia Clinica, Cancun October 2012 Randie R. Little, Ph.D. NGSP Network Laboratory
More informationPREANALYTICAL AND ANALYTICAL ASPECTS AFFECTING CLINICAL RELIABILITY OF PLASMA GLUCOSE RESULTS. Sara Pasqualetti
PREANALYTICAL AND ANALYTICAL ASPECTS AFFECTING CLINICAL RELIABILITY OF PLASMA GLUCOSE RESULTS Sara Pasqualetti TOTAL VARIABILITY OF LABORATORY TEST RESULTS V TOT = (V P 2 + V A2 + V I2 ) 1/2 PREANALYTICAL
More informationObservations on US CVD Prevention Guidelines. Donald M. Lloyd-Jones, MD ScM FACC FAHA
Observations on US CVD Prevention Guidelines Donald M. Lloyd-Jones, MD ScM FACC FAHA What are Guidelines? Evidence Base for Guidelines Tricoci, JAMA 2009 Evidence Base for Guidelines Tricoci, JAMA 2009
More informationEvaluation of Cheongmeak DCS TM Reagents for Chemistry Analyzers
임상검사와정도관리 J Lab Med Qual Assur 2010 ; 32:197-204 ISSN 1225-097X Evaluation of Cheongmeak DCS TM Reagents for Chemistry Analyzers Kyeong Seob Shin, Taek Eun Jeong, and Bo Ra Son Department of Laboratory
More informationŻurawska Gajane et.al, HTL-STREFA S.A. HTL-STREFA S.A Printed by the HTL-STREFA S.A., Warsaw, Poland.
A single-blind, randomized, single-centre study to investigate the characteristics of different personal lancets on blood volume and perceived pain in patients with diabetes mellitus Żurawska Gajane et.al,
More informationBiological Variation in Urine Samples Used for Analyte Measurements
CLIN. CHEM. 40/3, 472-477 (1994) #{149} Laboratory Management and Utilization Biological Variation in Urine Samples Used for Analyte Measurements Carmen Ric#{243}s, Carlos Victor Jim#{233}nez,2 Amparo
More informationThe effect of measurement uncertainty for HOMA-IR in assessment of insulin resistance
Available online at www.medicinescience.org ORIGINAL RESEARCH Medicine Science International Medical Journal Medicine Science 2018;( ): The effect of measurement uncertainty for HOMA-IR in assessment of
More informationReport on the accuracy and precision of the CSIRO laboratory method for predicting Glycemic Index
Report on the accuracy and precision of the CSIRO laboratory method for predicting Glycemic Index Dr Tony Bird 16 August 2011 Commercial in Confidence Enquiries should be addressed to: Dr Tony Bird Principal
More informationReview Sheet. 2) Which branch of science broken into chemistry and physics? a. Life science b. Earth science c. Biology d.
Multiple Choice: Circle each answer. Review Sheet 1) Which famous scientist was known for his/her work in radioactivity? a. Albert Einstein b. Marie Curie c. Thomas Edison d. Pierre Curie 2) Which branch
More informationNew Guidelines for the Diagnosis of Diabetes Mellitus
New Guidelines for the Diagnosis of Diabetes Mellitus Joely Straseski, PhD, DABCC, FACB Assistant Professor and Medical Director Endocrinology and Automated Core Laboratory University of Utah and ARUP
More information1 PROTOCOL. Comparison Study Summary. Springs Memorial Hospital. Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC (803)
Comparison Study Summary Springs Memorial Hospital 800 W. Meeting St. Lancaster, SC 29720 (803) 286-1480 February 10, 2016 1 PROTOCOL This evaluation was conducted on February 10, 2016 at Springs Memorial
More informationFIT - A Tale of Two Settings. Callum G Fraser Centre for Research into Cancer Prevention and Screening University of Dundee Scotland
FIT - A Tale of Two Settings Callum G Fraser Centre for Research into Cancer Prevention and Screening University of Dundee Scotland Possible Conflicts of Interest Consultant: Kyowa, Tokyo, Japan Consultant:
More informationDetermination of hemoglobin is one of the most commonly
ORIGINAL ARTICLE Multiple-Site Analytic Evaluation of a New Portable Analyzer, HemoCue Hb 201+, for Point-of-Care Testing Sten-Erik Bäck, PhD,* Carl G. M. Magnusson, PhD, Lena K. Norlund, MD, PhD, Henning
More informationCASE STUDY 3: PSA-STANDARDISATION & VARIABILITY COMPARATIVE STUDY IN HOSPITALS
CASE STUDY 3: PSA-STANDARDISATION & VARIABILITY COMPARATIVE STUDY IN HOSPITALS Dr Ophelia Blake FRCPath University Hospital Limerick, IRELAND JCTLM Meeting BIPM, Sevres,France 4 th December 2013 Prostate
More informationForum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007
Forum for Collaborative HIV Research External Validation of CD4 and Viral Load Assays Paris, France June 29, 2007 Thomas J. Spira, M.D. International Laboratory Branch Global AIDS Program Centers for Disease
More informationElements of analytical quality a historical review
EQALM symposium, Barcelona October 2016 Adam Uldall Lecture Elements of analytical quality a historical review Per Hyltoft Petersen Pensioner, Odense, Denmark NOKLUS, University of Bergen, Norway Hillerød
More informationGlucoMen LX PLUS blood glucose and blood ketone meter. Accuracy Evaluation to New ISO 15197:2013, with Technical and Specification Data
GlucoMen LX PLUS: Accuracy Evaluations to ISO 15197:2013 with Technical and Specification Data GlucoMen LX PLUS blood glucose and blood ketone meter Accuracy Evaluation to New ISO 15197:2013, with Technical
More informationDirect HbA1c testing capabilities on the RX modena
Direct testing capabilities on the RX modena INTRODUCTION What is? The term refers to glycated haemoglobin. It develops when haemoglobin, a protein within red blood cells that carries oxygen throughout
More informationAina Blood Monitoring System
Aina Blood Monitoring System Analytical Performance Summary The Aina Blood Monitoring System is a high quality and versatile multi-parameter diagnostic platform that is CE-marked and approved for sale
More informationImplementation of HbA1c as a Diagnostic Test in New Zealand
Implementation of HbA1c as a Diagnostic Test in New Zealand Chris Florkowski MD MRCP(UK) FRACP FRCPA FFSc Consultant in Chemical Pathology, Canterbury Health Laboratories Diabetes Physician, Christchurch
More informationJournal of Diabetes and Metabolic Disorders; 2011; Vol 10, pp 1-6. Keywords: Glycated hemoglobin, Paper filter, Diabetes, Dried blood spot.
Journal of Diabetes and Metabolic Disorders; 2011; Vol 10, pp 1-6 Glycated hemoglobin measurements from dried blood spots: reliability and relation to results obtained from whole blood samples Ozra Tabatabaei-Malazy
More informationWeek 17 and 21 Comparing two assays and Measurement of Uncertainty Explain tools used to compare the performance of two assays, including
Week 17 and 21 Comparing two assays and Measurement of Uncertainty 2.4.1.4. Explain tools used to compare the performance of two assays, including 2.4.1.4.1. Linear regression 2.4.1.4.2. Bland-Altman plots
More informationICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5
European Medicines Agency October 2008 EMEA/CHMP/ICH/383/1995 ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON DOSE SELECTION FOR CARCINOGENICITY
More informationChallenges in Performing a Scientifically Meaningful Lipemic Plasma Test in Bioanalytical Method Validation
Challenges in Performing a Scientifically Meaningful Lipemic Plasma Test in Bioanalytical Method Validation Laurence Mayrand-Provencher, Milton Furtado, Jean- Nicholas Mess, Josée Michon, Annik Bergeron,
More informationThe Virtues and Pitfalls of Implementing a New Test
The Virtues and Pitfalls of Implementing a New Test James H. Nichols, Ph.D., DABCC, FACB Professor of Clinical Pathology, Microbiology and Immunology Associate Medical Director for Clinical Operations
More informationFaculty/Presenter Disclosure I WOULD NEVER ORDER THAT FOR THAT PERSON; LAB USE AND MISUSE IN ALBERTA 19/10/2016
I WOULD NEVER ORDER THAT FOR THAT PERSON; LAB USE AND MISUSE IN ALBERTA Trefor Higgins DynaLIFEDx Edmonton, Alberta Faculty/Presenter Disclosure Presenter: Trefor Higgins Relationships that may introduce
More informationClient Report Screening Program Results For: Missouri Western State University October 28, 2013
Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening
More informationPsychology, 2010, 1: doi: /psych Published Online August 2010 (
Psychology, 2010, 1: 194-198 doi:10.4236/psych.2010.13026 Published Online August 2010 (http://www.scirp.org/journal/psych) Using Generalizability Theory to Evaluate the Applicability of a Serial Bayes
More informationAccuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips
Accuracy and Precision in Point-of-Care Lipid Testing: CardioChek P A Point-of-Care Test System and PTS Panels Test Strips Sponsored by Arthur Roberts, MD of The Living Heart Foundation The Living Heart
More informationRethinking Tradi.onal QA/QC: Weaknesses of Current Prac.ces; Six Sigma Metrics and Tools for Improvement
Rethinking Tradi.onal QA/QC: Weaknesses of Current Prac.ces; Six Sigma Metrics and Tools for Improvement James O. Westgard Sten A. Westgard Westgard QC, Inc. Madison, WI www.westgard.com 1 Hospitals recognize
More informationEffect of serum-clot contact time on clinical chemistry laboratory results
Clinical Chemistry 44:6 1325 1333 (1998) General Clinical Chemistry Effect of serum-clot contact time on clinical chemistry laboratory results Dongbo J. Zhang, 1 R.K. Elswick, 2 W. Greg Miller, 1* and
More informationPolymer Technology Systems, Inc. CardioChek PA Comparison Study
Polymer Technology Systems, Inc. CardioChek PA Comparison Study Evaluation Protocol: Accuracy Precision Clinical Correlation PTS Panels Lipid Panel Test Strips For Use in Comparisons to a Reference Laboratory
More informationSelecting a Hemoglobin A1C Point of Care Instrument. Objectives. Disclosure / Conflict of Interest 3/11/2015
Selecting a Hemoglobin A1C Point of Care Instrument Heather P. Whitley, PharmD, BCPS, CDE Associate Clinical Professor of Pharmacy Practice Auburn University Harrison School of Pharmacy Objectives Compare
More informationImmediate Pathology Results Now Available for all Remote Northern Territorians
Immediate Pathology Results Now Available for all Northern Territorians Brooke Spaeth, BMedSc (Hons) Coordinator - Northern Territory Point-of-Care Testing Program Flinders University International Centre
More informationSelecting a Risk-Based SQC Procedure for a HbA1c Total QC Plan
729488DSTXXX10.1177/1932296817729488Journal of Diabetes Science and TechnologyWestgard et al research-article2017 Original Article Selecting a Risk-Based SQC Procedure for a HbA1c Total QC Plan Journal
More informationQUANTIFYING THE EFFECT OF SETTING QUALITY CONTROL STANDARD DEVIATIONS GREATER THAN ACTUAL STANDARD DEVIATIONS ON WESTGARD RULES
AACC24 QUANTIFYING THE EFFECT OF SETTING QUALITY CONTROL STANDARD DEVIATIONS GREATER THAN ACTUAL STANDARD DEVIATIONS ON WESTGARD RULES Graham Jones Department of Chemical Pathology, St Vincent s Hospital,
More informationMETHOD VALIDATION CASE
METHOD VALIDATION CASE METHOD VALIDATION PROTOCOL CLIA Regulation 493.1253 (2) 1.Accuracy (closeness to true/comparative method) 2.Precision (reproducibility) 3.Reference Interval 4.Reportable range (linearity,
More informationARTICLE. Utility of Direct Measurement of Low-Density Lipoprotein Cholesterol in Dyslipidemic Pediatric Patients
ARTICLE Utility of Direct Measurement of Low-Density Lipoprotein Cholesterol in Dyslipidemic Pediatric Patients Baruch S. Ticho, MD, PhD; Ellis J. Neufeld, MD, PhD; Jane W. Newburger, MD, MPH; Neil Harris,
More informationQuality specifications for seminal parameters based on the state of the art
Human Reproduction Vol.20, No.9 pp. 2573 2578, 2005 Advance Access publication May 19, 2005 doi:10.1093/humrep/dei061 Quality specifications for seminal parameters based on the state of the art J.A.Castilla
More informationMethod Comparison Report Semi-Annual 1/5/2018
Method Comparison Report Semi-Annual 1/5/2018 Prepared for Carl Commissioner Regularatory Commission 123 Commission Drive Anytown, XX, 12345 Prepared by Dr. Mark Mainstay Clinical Laboratory Kennett Community
More informationCase # 278 Should lipoprotein cholesterol assays disappear?
Case # 278 Should lipoprotein cholesterol assays disappear? Let's get into the case: I was contacted by a provider who states: "I have a 70 year old guy with absolutely no cardiac risk factors except for
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationAnalytic Bias of Thyroid Function Tests. Analysis of a College of American Pathologists Fresh Frozen Serum Pool by 3900 Clinical Laboratories
Analytic Bias of Thyroid Function Tests Analysis of a College of American Pathologists Fresh Frozen Serum Pool by 3900 Clinical Laboratories Bernard W. Steele, MD; Edward Wang, PhD; George G. Klee, MD,
More informationWhat information on measurement uncertainty should be communicated to clinicians, and how? Mario Plebani
What information on measurement uncertainty should be communicated to clinicians, and how? Mario Plebani OUTLINE OF TALK Uncertainty in medicine and shared decision making Measurement uncertainty in laboratory
More informationInitiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator
Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator H Thom 1 BSc (Hons), Paediatric Diabetes Dietitian S Greene
More informationDiagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter
Diagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter Diabetes may be diagnosed on any of the following criteria (WHO 2006,
More informationDiabetes, Diet and SMI: How can we make a difference?
Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative
More informationQuality Initiative In Pathology. Harmonisation of Laboratory Testing
Quality Initiative In Pathology Harmonisation of Laboratory Testing Harmonisation: what do we mean? Agreement of test results irrespective of the method used or the testing laboratory Requires: Common
More informationThe who, what, why, where, and when of Clinical Practice Guidelines (CPGs)
The who, what, why, where, and when of Clinical Practice Guidelines (CPGs) Appraisal of Guidelines for Research and Evaluation (AGREE) II DOMAIN 1. SCOPE AND PURPOSE DOMAIN 2. STAKEHOLDER INVOLVEMENT DOMAIN
More informationMETHOD VALIDATION CASE
METHOD VALIDATION CASE METHOD VALIDATION PROTOCOL CLIA Regulation 493.1253 (2) 1.Accuracy (closeness to true/comparative method) 2.Precision (reproducibility) 3.Reference Interval 4.Reportable range (linearity,
More informationMeasurement and Estimation of renal function. Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE
Measurement and Estimation of renal function Professeur Pierre Delanaye Université de Liège CHU Sart Tilman BELGIQUE 1 2 How to estimate GFR? How to measure GFR? How to estimate GFR? How to measure GFR?
More informationEquivalent Accuracy Evaluation of FORA Premium V10 Blood Glucose Monitoring System as Compared to Fora V30 Blood Glucose Monitoring System
Equivalent Accuracy Evaluation of FORA Premium V10 Blood Glucose Monitoring System as Compared to Fora V30 Blood Glucose Monitoring System Abstract Objective: Both Fora Premium V10 and V30 blood glucose
More informationIn Vitro Diagnostic Glucose Test System
CDRH Final Guidance 2-Page Cover Sheet Guidance for Industry In Vitro Diagnostic Glucose Test System Document issued on: July 6, 1998 U.S. Department Of Health and Human Services Food and Drug Administration
More informationCoverage Guidelines. NMR LipoProfile and NMR LipoProfile -II Tests
Coverage Guidelines NMR LipoProfile and NMR LipoProfile -II Tests Disclaimer: Please note that Baptist Health Plan updates Coverage Guidelines throughout the year. A printed version may not be most up
More informationDIABETES AND LABORATORY TESTS. Author: Josephine Davis
DIABETES AND LABORATORY TESTS Author: Josephine Davis LAB TESTS Think twice before you test. What is the reason for testing? Laboratory tests are generally requested in primary care for one of the following
More informationFour rules to remember: 1) Addition, subtraction, multiplication and division of SD and/or CV.
Analytical Quality Specifications for Thyroid Hormones Bayer Nordic Users Meeting, 17. September 2001. Frode Engbaek, Ph. D., Department of Clinical Biochemistry, Aarhus Kommunehospital, DK-8000 Aarhus
More informationBiological Variations of Hematologic Parameters Determined by UniCel DxH 800 Hematology Analyzer
Biological Variations of Hematologic Parameters Determined by UniCel DxH 800 Hematology Analyzer Pianhong Zhang, PhD; Huqiang Tang, MS, MPH; Keqing Chen, MS; Yingying Chen, BS; Dongsheng Xu, MD, PhD Context.
More informationPolicy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the
More informationValidation Case studies: the good, the bad and the molecular
Validation Case studies: the good, the bad and the molecular Patti Jones PhD Professor of Pathology UT Southwestern Medical Center Director of Chemistry Children s Medical Center Dallas Presented by AACC
More informationCollege of American Pathologists (CAP) GH2 Survey Data: (updated 12/09) 2009 GH2-B (fresh pooled samples) * = NGSP certified at the time of the survey
College of American Pathologists (CAP) GH2 Survey Data: (updated 12/09) The American Diabetes Association (ADA) recommends that laboratories use only HbA1c assay methods that have been NGSP certified and
More informationElectrolyte-balanced heparin in blood gas syringes can introduce a significant bias in the measurement of positively charged electrolytes
Electrolyte-balanced heparin in blood gas syringes can introduce a significant bias in the measurement of positively charged electrolytes Citation for published version (APA): Berkel, van, M., & Scharnhorst,
More informationLaboratory Medicine Standardization Activity in Japan
JCTLM 15/11/2005 Sevres, Paris oratory Medicine Standardization Activity in Japan National Institute Metrology of Japan (NMIJ) Koichi Chiba Fujirebio Inc. Katsuhiko Yamamoto University of Tsukuba Katsuhiko
More informationValidity and reliability of measurements
Validity and reliability of measurements 2 3 Request: Intention to treat Intention to treat and per protocol dealing with cross-overs (ref Hulley 2013) For example: Patients who did not take/get the medication
More informationDANGEROUS GOODS PANEL (DGP)
International Civil Aviation Organization WORKING PAPER 24/10/05 English only DANGEROUS GOODS PANEL (DGP) TWENTIETH MEETING Montréal, 24 October to 4 November 2005 Agenda Item 2: Development of recommendations
More informationCalibration of ion-exchange HPLC measurements of glycohemoglobin: effect on interassay precision
Clinical Chemistry 43:12 2353 2357 (1997) Endocrinology and Metabolism Calibration of ion-exchange HPLC measurements of glycohemoglobin: effect on interassay precision Erik Gerlo* and Frans Gorus To investigate
More informationMonitoring Public Health Nutrition in Europe Appendix X (Page 1 of 4) Technical Report, Agreement SI (2000CVG3-507)
Monitoring Public Health Nutrition in Europe Appendix X (Page 1 of 4) EFCOSUM; Executive summary Introduction The project European Food Consumption Survey Method (EFCOSUM) was undertaken within the framework
More information